🇺🇸 FDA
Patent

US 8133915

Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators

granted A61PA61P1/02A61P1/16

Quick answer

US patent 8133915 (Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators) held by The Regents of the University of California expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P1/02, A61P1/16, A61P11/02, A61P17/00